ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
22 hedge funds and large institutions have $471K invested in Oncternal Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16K | |
| 2 | +$2.9K | |
| 3 | +$1.48K | |
| 4 |
Renaissance Technologies
New York
|
+$924 |
| 5 |
BlackRock
New York
|
+$565 |
Top Sellers
| 1 | -$200K | |
| 2 | -$188K | |
| 3 | -$129K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$116K |
| 5 |
Millennium Management
New York
|
-$55.1K |